stoxline Quote Chart Rank Option Currency Glossary
  
Olink Holding AB (publ) (OLK)
23.52  -0.08 (-0.34%)    03-28 10:24
Open: 23.6
High: 23.78
Volume: 24,296
  
Pre. Close: 23.6
Low: 23.5
Market Cap: 2,925(M)
Technical analysis
2024-03-28 9:47:48 AM
Short term     
Mid term     
Targets 6-month :  28.84 1-year :  33.69
Resists First :  24.7 Second :  28.84
Pivot price 23.97
Supports First :  22.83 Second :  21.68
MAs MA(5) :  24 MA(20) :  23.76
MA(100) :  24.69 MA(250) :  21.25
MACD MACD :  0 Signal :  0
%K %D K(14,3) :  31.6 D(3) :  58.5
RSI RSI(14): 45.7
52-week High :  26.01 Low :  14.1
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ OLK ] has closed above bottom band by 13.2%. Bollinger Bands are 37.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 24.2 - 24.36 24.36 - 24.49
Low: 23.25 - 23.41 23.41 - 23.54
Close: 23.37 - 23.62 23.62 - 23.84
Company Description

Olink Holding AB (publ) provides various products and services for the academic, government, biopharmaceutical, biotechnology, and other institutions that focuses on life science research. Its products include Olink Explore for cardiovascular and metabolic, oncology, neurology, or inflammation diseases; Olink Target product line; and Olink Focus product line that consists of custom developed solutions for customers that has identified various proteins of interest or a protein signature to focus on. The company's products also comprise Olink Signature Q100, a qPCR readout platform; Olink Analysis services comprising study design and consultation, sample preparation and assay execution, and data processing and QC; and bioinformatics services. In addition, it provides Olink normalized protein expression (NPX) Manager, a purpose-built software that enable users to import data, validate data quality, and normalize for subsequent statistical analysis; and Olink Insight, a cloud platform for data visualization and statistical analysis of NPX data. Olink Holding AB (publ) sells its products and services through its own direct sales force in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company was formerly known as Knilo HoldCo AB and changed its name to Olink Holding AB (publ) in January 2021. The company was founded in 2004 and is headquartered in Uppsala, Sweden. Olink Holding AB (publ) is a subsidiary of Summa Equity Holding AB.

Headline News

Thu, 28 Mar 2024
Leerink Partnrs Weighs in on Olink Holding AB (publ)'s Q1 2025 Earnings (NASDAQ:OLK) - MarketBeat

Thu, 28 Mar 2024
Olink Holding AB (publ) (NASDAQ:OLK) Just Reported And Analysts Have Been Cutting Their Estimates - Simply Wall St

Wed, 27 Mar 2024
These Analysts Think Olink Holding AB (publ)'s (NASDAQ:OLK) Sales Are Under Threat - Yahoo Canada Finance

Wed, 27 Mar 2024
Olink Holding Full Year 2023 Earnings: Misses Expectations - Simply Wall St

Wed, 27 Mar 2024
Olink Holding AB (publ) (NASDAQ:OLK) Receives Hold Rating from Canaccord Genuity Group - Defense World

Wed, 27 Mar 2024
Olink Holding AB (publ) (NASDAQ:OLK) Stock Rating Reaffirmed by Morgan Stanley - Defense World

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Outperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Neutral
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Neutral
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Diagnostics & Research
Shares Out 0 (M)
Shares Float 124 (M)
Held by Insiders 4.096e+007 (%)
Held by Institutions 68.1 (%)
Shares Short 1,950 (K)
Shares Short P.Month 0 (K)
Stock Financials
EPS -2.265e+007
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin 0 %
Operating Margin -11.8 %
Return on Assets (ttm) -17.4 %
Return on Equity (ttm) -4.6 %
Qtrly Rev. Growth 1.5893e+008 %
Gross Profit (p.s.) 79.59
Sales Per Share -8.94
EBITDA (p.s.) 0
Qtrly Earnings Growth -0.2 %
Operating Cash Flow 0 (M)
Levered Free Cash Flow -27 (M)
Stock Valuations
PE Ratio -0.01
PEG Ratio 215.5
Price to Book value 0
Price to Sales -2.65
Price to Cash Flow 3.04
Stock Dividends
Dividend 0
Forward Dividend 1.67e+006
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android